- Market cap
- $173.28M
- 52w range
- $5.05 - $9.13
- Beta
- 1.59
- Sector
- Healthcare
- Data quality
- 83/100
- fair value estimate
- $6.68
- Margin of safety
- +11.7%
- Moat score
- 29/100
- Return on equity
- -13.1%
- Profit margin
- -7.1%
- Debt / equity
- 0.09
- Revenue growth
- +3.4%
- Analyst target
- $12.67
- Target upside
- +111.8%
- Analysts
- 3
About Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Valuation
Derived from filed metrics · High confidence (83% of the inputs available)
Moat, fair value and rating computed by our valuation engine (ported from the original Python model).